Chemotherapy for adult soft tissue sarcoma
Open Access
- 1 January 1997
- journal article
- other
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 68 (sup273) , 139-144
- https://doi.org/10.1080/17453674.1997.11744720
Abstract
(1997). Chemotherapy for adult soft tissue sarcoma. Acta Orthopaedica Scandinavica: Vol. 68, The Scandinavian—Australian Symposium on the Management of Bone and Soft Tissue Sarcomas, pp. 139-144.This publication has 19 references indexed in Scilit:
- MDR1 gene expression: Evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomasEuropean Journal Of Cancer, 1996
- P-Glycoprotein — A Marker of Cancer-Cell BehaviorNew England Journal of Medicine, 1995
- Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trialsBritish Journal of Cancer, 1995
- Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposideCancer Chemotherapy and Pharmacology, 1995
- Dose effect / High dose chemotherapyAnnals of Oncology, 1992
- Chemotherapy for metastatic soft tissue sarcomas – another full circle?British Journal of Cancer, 1991
- Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastasesThe Annals of Thoracic Surgery, 1991
- Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.Journal of Clinical Oncology, 1989
- Chemotherapy of advanced soft‐tissue sarcomasSeminars in Surgical Oncology, 1988
- VP-16 in advanced soft tissue sarcoma: A phase II study of the EORTC soft tissue and bone sarcoma groupEuropean Journal of Cancer and Clinical Oncology, 1987